Home » Stocks » INVO

INVO Bioscience, Inc. (INVO)

Stock Price: $3.94 USD 0.23 (6.20%)
Updated May 12, 2021 4:00 PM EDT - Market closed
After-hours: $4.00 +0.06 (1.52%) May 12, 7:56 PM
Market Cap 41.59M
Revenue (ttm) 1.04M
Net Income (ttm) -8.35M
Shares Out 10.42M
EPS (ttm) -1.52
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 12
Last Price $3.94
Previous Close $3.71
Change ($) 0.23
Change (%) 6.20%
Day's Open 3.90
Day's Range 3.85 - 4.08
Day's Volume 123,529
52-Week Range 2.90 - 12.30

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

SARASOTA, Fla., May 11, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOcel...

1 day ago - PRNewsWire

SARASOTA, Fla., May 10, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOcel...

2 days ago - PRNewsWire

SARASOTA, Fla., April 26, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOc...

2 weeks ago - PRNewsWire

SARASOTA, Fla., April 22, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOc...

2 weeks ago - PRNewsWire

SARASOTA, Fla. and SAN FRANCISCO, April 19, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture S...

3 weeks ago - PRNewsWire

VNET, ALTG, FPI, HALL, and INVO have been added to the Zacks Rank #5 (Strong Sell) List on April 16, 2021

Other stocks mentioned: ALTG, FPI, HALL, VNET
3 weeks ago - Zacks Investment Research

SARASOTA, Fla., April 12, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and devel...

1 month ago - PRNewsWire

SARASOTA, Fla., March 30, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and devel...

1 month ago - PRNewsWire

SARASOTA, Fla., March 29, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOc...

1 month ago - PRNewsWire

SARASOTA, Fla., March 26, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOc...

1 month ago - PRNewsWire

SARASOTA, Fla., March 11, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOc...

2 months ago - PRNewsWire

Shares of INVO Bioscience, Inc. (NASDAQ: INVO) gained more than 202% in the regular trading session on Tuesday. What Happened: The sharp gains came after the Sarasota, Massachusetts-based medical device...

2 months ago - Benzinga

INVO stock is on the move Tuesday after INVO Bioscience announced plans to expand its fertility clinic footprint. The post INVO Stock: Why INVO Bioscience Is Skyrocketing Today appeared first on Investo...

2 months ago - InvestorPlace

Invo Bioscience Inc (NASDAQ: INVO) shares have gained sharply after an amendment under its exclusive U.S. commercialization agreement with Ferring Pharmaceuticals. The amendment provides an increase in ...

2 months ago - Benzinga

SARASOTA, Fla., March 8, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOce...

2 months ago - PRNewsWire

SARASOTA, Fla., March 1, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOce...

2 months ago - PRNewsWire

SARASOTA, Fla., Jan. 15, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOce...

3 months ago - PRNewsWire

About INVO

INVO Bioscience, Inc., a medical device company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a patented intravaginal culture system used for the natural in vivo incubation of eggs and sperm during fertilization and early embryo development. The company was founded in 2007 and is based in Sarasota, Massachusetts.

Industry
Medical Devices
Founded
2007
Stock Exchange
NASDAQ
Ticker Symbol
INVO
Full Company Profile

Financial Performance

In 2020, INVO's revenue was $1.04 million, a decrease of -29.92% compared to the previous year's $1.48 million. Losses were -$8.35 million, 285.1% more than in 2019.

Financial Statements

Analyst Forecasts

According to 2 analysts, the average rating for INVO stock is "Buy." The 12-month stock price forecast is 5.88, which is an increase of 49.24% from the latest price.

Price Target
$5.88
(49.24% upside)
Analyst Consensus: Buy